Gathering and exploring scientific knowledge in pharmacovigilance

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Lopes, Pedro ^a   Nunes, Tiago ^a   Campos, David ^a   Furlong, Laura Ines ^b   Bauer Mehren, Anna ^b   Sanz, Ferran ^b   Carrascosa, Maria Carmen ^b   Mestres, Jordi ^b   Kors, Jan ^c   Singh, Bharat ^c   Van Mulligen, Erik ^c   Van Der Lei, Johan ^c   Diallo, Gayo ^d   Avillach, Paul ^d,e   Ahlberg, Ernst ^f   Boyer, Scott ^f   Diaz, Carlos ^g   Oliveira, José Luís ^a  

^a UNIVERSITY OF AVEIRO   (Portugal)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e AIX MARSEILLE UNIVERSITY   (France)

^f ASTRAZENECA R AND D   (Sweden)

^g Synapse Research Management Partners   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; COMPUTER PROGRAM; DATA BASE; DRUG SURVEILLANCE PROGRAM; KNOWLEDGE; MEDICAL RESEARCH; SCORING SYSTEM; WEB BROWSER; DRUG INTERACTION; FEMALE; HUMAN; INTERNET; MALE;

DRUG INTERACTIONS; FEMALE; HUMANS; INTERNET; MALE; PHARMACOVIGILANCE; SOFTWARE;

EID: 84892404109     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083016     Document Type: Article

References (56)

1. McClure DL (2009) Improving Drug Safety: Active Surveillance Systems Should be Paramount. Pharmaceutical Medicine 23: 127-130. doi:10.1007/ BF03256760.
2. Shibata A, Hauben M (2011) Pharmacovigilance, signal detection and signal intelligence overview. Proceedings of the 14th International Conference on Information Fusion (FUSION). Chicago, IL. pp. 1-7.
3. Ema Ema (2010) Annual Report. European Medicines Agency.
4. Robb MA, Racoosin JA, Sherman RE, Gross TP, Ball R et al. (2012) The US Food and Drug Administration's Sentinel Initiative: Expanding the horizons of medical product safety. Pharmacoepidemiol Drug Saf 21: 9-11. doi:10.1002/pds.2311. PubMed: 22262587.
5. Xu L, Anchordoquy T (2011) Drug delivery trends in clinical trials and translational medicine: Challenges and opportunities in the delivery of nucleic acid-based therapeutics. J Pharm Sci 100: 38-52. doi:10.1002/jps.22243. PubMed: 20575003.
6. Nelson JC, Cook AJ, Yu O, Dominguez C, Zhao S et al. (2012) Challenges in the design and analysis of sequentially monitored postmarket safety surveillance evaluations using electronic observational health care data. Pharmacoepidemiol Drug Saf 21: 62-71. doi:10.1002/pds.2324. PubMed: 22262594.
7. Staffa JA, Dal Pan GJ (2012) Regulatory Innovation in Postmarketing Risk Assessment and Management. Clin Pharmacol Ther 91: 555-557. doi:10.1038/clpt. 2011.289. PubMed: 22297386.
8. Stahl M, Edwards IR, Bowring G, Kiuru A, Lindquist M (2003) Assessing the Impact of Drug Safety Signals from the WHO Database Presented inSIGNAL': Results from a Questionnaire of National Pharmacovigilance Centres. Drug safety 26: 721-727
9. Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279: 1200-1205. doi:10.1001/jama.279.15.1200. PubMed: 9555760.
10. Meyboom RHB, Lindquist M, Egberts ACG, Edwards IR (2002) Signal Selection and Follow-Up in Pharmacovigilance. Drug Safety 25: 459-465. doi:10.2165/00002018-200225060-00011. PubMed: 12071784.
11. Alvarez-Requejo A, Carvajal A, Bégaud B, Moride Y, Vega T et al. (1998) Under-reporting of adverse drug reactions Estimate based on a spontaneous reporting scheme and a sentinel system. Eur J Clin Pharmacol 54: 483-488. doi:10.1007/s002280050498. PubMed: 9776440.
12. Grootheest V (1999) Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol 48: 623-627. PubMed: 10583035.
13. De Bruin ML, Van Puijenbroek EP, Egberts AC, Hoes AW, Leufkens HG (2002) Non-sedating antihistamine drugs and cardiac arrhythmias - biased risk estimates from spontaneous reporting systems? Br J Clin Pharmacol 53: 370-374. doi:10.1046/j.1365-2125.2002.01569.x. PubMed: 11966667.
14. Coloma PM, Schuemie MJ, Trifirò G, Gini R, Herings R et al. (2011) Combining electronic healthcare databases in Europe to allow for largescale drug safety monitoring: the EU-ADR Project. Pharmacoepidemiol Drug Saf 20: 1-11. doi:10.1002/pds.2206. PubMed: 21182150.
15. Härmark L, Van Grootheest AC (2008) Pharmacovigilance: methods, recent developments and future perspectives. Eur J Clin Pharmacol 64: 743-752. doi:10.1007/s00228-008-0475-9. PubMed: 18523760.
16. Trontell AE (2005) The RADAR Project and the FDA. JAMA 294: 1206. doi:10.1001/jama.294.10.1206-a. PubMed: 16160128.
17. Platt R, Carnahan R (2012) The US Food and Drug Administration's Mini-Sentinel Program. Pharmacoepidemiology and Drug Safety 21: 1-303. doi:10.1002/pds.3324.
18. Trifiro G, Fourrier-Reglat A, Sturkenboom MCJM, Díaz Acedo C, Van Der Lei J et al. (2009) The EU-ADR project: preliminary results and perspective. Stud Health Technol Inform 148: 43-49. PubMed: 19745234.
19. Stang PE, Ryan PB, Racoosin JA, Overhage JM, Hartzema AG et al. (2010) Advancing the Science for Active Surveillance: Rationale and Design for the Observational Medical Outcomes Partnership. Ann Intern Med 153: 600-606. doi: 10.7326/0003-4819-153-9-201011020-00010. PubMed: 21041580.
20. Ryan PB, Madigan D, Stang PE, Marc Overhage J, Racoosin JA et al. (2012) Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership. Stat Med 31: 4401-4415. doi:10.1002/sim.5620. PubMed: 23015364.
21. Schuemie MJ (2011) Methods for drug safety signal detection in longitudinal observational databases: LGPS and LEOPARD. Pharmacoepidemiol Drug Saf 20: 292-299. doi:10.1002/pds.2051. PubMed: 20945505.
22. Platt R, Wilson M, Chan KA, Benner JS, Marchibroda J et al. (2009) The New Sentinel Network - Improving the Evidence of Medical-Product Safety. N Engl J Med 361: 645-647. doi:10.1056/NEJMp0905338. PubMed: 19635947.
23. Behrman RE, Benner JS, Brown JS, McClellan M, Woodcock J et al. (2011) Developing the Sentinel System - A National Resource for Evidence. Development - New England Journal of Medicine 364: 498-499. doi:10.1056/NEJMp1014427.
24. Curtis LH, Weiner MG, Boudreau DM, Cooper WO, Daniel GW et al. (2012) Design considerations, architecture, and use of the Mini-Sentinel distributed data system. Pharmacoepidemiol Drug Saf 21: 23-31. doi:10.1002/pds.2336. PubMed: 22262590.
25. Gini R, Coppola M, Ryan PB, Righetti G, Peri I et al. (2013) Frameworks for Data Extraction and Management from Electronic Healthcare Databases for Multi-Center Epidemiologic Studies: a Comparison among EU-ADR, MATRICE, and OMOP Strategies. 29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management. Montréal. Canada.
26. Trifirò G, Patadia V, Schuemie MJ, Coloma PM, Gini R et al. (2011) EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection. Stud Health Technol Inform 166: 25-30. PubMed: 21685607.
27. Wilke RA, Xu H, Denny JC, Roden DM, Krauss RM et al. (2011) The Emerging Role of Electronic Medical Records in Pharmacogenomics. Clin Pharmacol Ther 89: 379-386. doi:10.1038/clpt.2010.260. PubMed: 21248726.
28. Coloma PM, Trifirò G, Schuemie MJ, Gini R, Herings R et al. (2012) Electronic healthcare databases for active drug safety surveillance: is there enough leverage? Pharmacoepidemiol Drug Saf 21: 611-621. doi: 10.1002/pds.3197. PubMed: 22315152.
29. Chan KA, Hauben M (2005) Signal detection in pharmacovigilance: empirical evaluation of data mining tools. Pharmacoepidemiol Drug Saf 14: 597-599. doi:10.1002/pds.1128. PubMed: 16134080.
30. Wilson AM, Thabane L, Holbrook A (2004) Application of data mining techniques in pharmacovigilance. Br J Clin Pharmacol 57: 127-134. PubMed: 14748811.
31. Koh HC, Tan G (2005) Data mining applications in healthcare. J Healthc Inf Manag 19: 64-72. PubMed: 15869215.
32. Fu Y, Chen Z, Koru G, Gangopadhyay A (2010) A privacy protection technique for publishing data mining models and research data. ACM Trans Manage Inf Syst 1: 1-20.
33. Avillach P, Coloma PM, Gini R, Schuemie M, Mougin F, et al. (2012) Harmonization process for the identification of medical events in eight European healthcare databases: the experience from the EU-ADR project. Journal of the American Medical Informatics Association.
34. Trifirò G, Pariente A, Coloma PM, Kors JA, Polimeni G et al. (2009) Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor? Pharmacoepidemiol Drug Saf 18: 1176-1184. doi:10.1002/pds.1836. PubMed: 19757412.
35. Oliveira JL, Lopes P, Nunes T, Campos D, Boyer S, et al. (2012) The EU-ADR Web Platform: delivering advanced pharmacovigilance tools. Pharmacoepidemiology and drug safety.
36. Hollingsworth D (1995) The Workflow Reference Model.
37. Petkov S, Oren E, Haller A (2005) Aspects in Workflow Management. Galway, Ireland: DERI, Digital Enterprise Research Institute. p. 20.
38. Ludascher B, Altintas I, Berkley C, Higgings D, Jaeger E et al. (2006) Taverna: Scientific Workflow Management and the Kepler System. Research Articles. Concurrency-Computation: Practice and Experience 18: 1039-1065. doi:10.1002/cpe.994.
39. Goecks J, Nekrutenko A, Taylor J (2010) Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol 11: R86. doi: 10.1186/gb-2010-11-8-r86. PubMed: 20738864.
40. Jamil H, El-Hajj-Diab B (2008) BioFlow: A Web-Based Declarative Workflow Language for Life Sciences. IEEE Congress on Services. Honolulu, HI, USA IEEE Computer Society. pp. 453-460.
41. Lopes P, Oliveira JL (2012) COEUS:"semantic web in a box" for biomedical applications. Journal of biomedical semantics 3: 1-19.
42. Shucheng Y, Cong W, Kui R, Wenjing L (2010) Achieving Secure, Scalable, and Fine-grained Data Access Control in Cloud Computing. Proc. IEEE INFOCOM. San Diego, CA, USA. pp. 1-9.
43. Cheung K-H, Yip KY, Townsend JP, Scotch M (2008) HCLS 2.0/3.0: Health care and life sciences data mashup using Web 2.0/3.0. Journal of Biomedical Informatics 41: 694-705.
44. Rui Z, Ling L (2010) Security Models and Requirements for Healthcare Application Clouds. Cloud Computing (CLOUD), 2010 IEEE 3rd International Conference on. pp. 268-275.
45. Baker A, Vega L, DeHart T, Harrison S (2011) Healthcare and Security: Understanding and Evaluating the Risks. In: Robertson, M., editor editor. Ergonomics and Health Aspects of Work with Computers. Berlin: Springer Berlin / Heidelberg. pp. 99-108
46. Coloma PM, Schuemie MJ, Trifirò G, Furlong L, van Mulligen E et al. (2013) Drug-Induced Acute Myocardial Infarction: Identifying 'Prime Suspects' from Electronic Healthcare Records-Based Surveillance. System - PLOS ONE 8: e72148. doi:10.1371/journal.pone.0072148.
47. Avillach P, Mougin F, Joubert M, Thiessard F, Pariente A et al. (2009) A semantic approach for the homogeneous identification of events in eight patient databases: a contribution to the European eu-ADR project. Stud Health Technol Inform 150: 190-194. PubMed: 19745295.
48. de Leon J (2011) Highlights of Drug Package Inserts and the Website DailyMed: The Need for Further Improvement in Package Inserts to Help Busy Prescribers. J Clin Psychopharmacol.
49. Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S et al. (2008) DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 36: D901-D906. PubMed: 18048412.
50. Bauher-Mehren A, Mulligen Ev Avillach P, Carrascosa M, Singh B et al. (2012) Automatic filtering and substantiation of drug safety signals. PLOS Computational Biololgy 8.
51. Zadeh LA (1986) A simple view of the Dempster-Shafer theory of evidence and its implication for the rule of combination. AI Magazine 7: 85.
52. Vilar S, Harpaz R, Chase HS, Costanzi S, Rabadan R, et al. (2011) Facilitating adverse drug event detection in pharmacovigilance databases using molecular structure similarity: application to rhabdomyolysis. Journal of the American Medical Informatics Association.
53. Papay J, Yuen N, Powell G, Mockenhaupt M, Bogenrieder T (2012) Spontaneous adverse event reports of Stevens - Johnson syndrome/toxic epidermal necrolysis: detecting associations with medications. Pharmacoepidemiol Drug Saf 21: 289-296. doi:10.1002/pds.2276. PubMed: 22139991.
54. Sommet A, Durrieu G, Lapeyre-Mestre M, Montastruc J-L, Association of French PharmacoVigilance Centres (2012) A comparative study of adverse drug reactions during two heat waves that occurred in France in 2003 and 2006. Pharmacoepidemiology and Drug Safety 21: 285-288.
55. Wang K, Bai X, Li J, Ding C (2010) A service-based framework for pharmacogenomics data integration. Enterprise - Information Systems 4: 225-245. doi:10.1080/17517575.2010.498525.
56. Dudley JT, Butte AJ (2010) In silico research in the era of cloud computing. Nat Biotechnol 28: 1181-1185. doi:10.1038/nbt1110-1181. PubMed: 21057489.